Semen Indonesia stock reports 471.13 percent profit growth

Semen Indonesia stock reported attributable profit of IDR 228.25 billion for the first half of 2026, up 471.13 percent from IDR 39.97 billion a year earlier. CNBC Indonesia reported the result on September 1, 2026, alongside revenue growth to IDR 17.65 trillion from IDR 15.60 trillion in the comparable period.

Revenue growth meets stronger profit

The first-half revenue increase was 13.08 percent year over year, while the company delivered a much larger improvement in attributable earnings. That gap points to operating leverage as the most important part of the recovery story.

Sales volume reached 18.28 million tons, up 5.60 percent year over year, and domestic volume climbed 9.70 percent to 14.18 million tons. Kontan reported the figures on September 9, 2026, and said EBITDA rose 2.60 percent to IDR 2.15 trillion.

Analyst target falls to IDR 2,502.06

The market is assigning a more cautious valuation despite the earnings rebound. Fintel reported on September 15, 2026, that the average one-year target had been reduced to IDR 2,502.06 from IDR 2,803.53 on August 25, 2026, a 10.75 percent decline.

The target range extended from IDR 1,340.27 to IDR 3,465.00, showing a wide spread in analyst expectations. Fintel also recorded 15 recommendations as of September 1, 2026, including 4 strong buy, 6 buy, 3 hold and 2 sell ratings.

IDX quote reaches IDR 1,485.00

On October 1, 2026, Semen Indonesia was last at IDR 1,485.00 on the IDX at 10:09 a.m. WIB, up 2.41 percent from the prior close of IDR 1,450.00. Market capitalization stood at IDR 10.0 trillion, while the 52-week range was IDR 1,380.00 to IDR 3,260.00.